Recent analyses of populations experiencing further waves of COVID-19 infection based on the Delta variant indicate that new challenges are emerging in the fight against the COVID-19 Pandemic: Some in-use vaccines are failing to provide long-run protection against the rapidly evolving COVID-19 virus, whereas others appear to be showing better long-term performance. See our analysis in our Industry Update 11.
The current situation with vaccines world-wide strongly supports the following hypotheses:
0 Comments
Global Pandemic
Vaccinations
Industry
Global Pandemic
Industry
Global Pandemic
The Business of Vaccines
Medical/ Vaccine Updates
There is a media debate as to whether the pandemic is stabilizing, or whether we are entering a dangerous new 3rd and 4th wave, driven by toxic new mutations to the virus, such as the UK, South African, and Brazilian variants. Refana's view is as follows:
Global Pandemic
Industry and Economics
March has seen warnings of a 4th Wave, emergency use approval for a 1-shot vaccine and an increase in vaccine sales. Volume 6 looks at these headlines and more. Global Pandemic
Industry
Financial news
Welcome to our first Industry Update, which brings you the latest news in Covid-19 Vaccine Developments and Industry Financial Updates. Covid-19 Vaccine Developments
Industry Financial Valuation Updates
|